Article

Synthesis and biological evaluation of bicyclo[3.3.0] octane derivatives as dipeptidyl peptidase 4 inhibitors for the treatment of type 2 diabetes.

Shanghai Hengrui Pharmaceuticals Co., Ltd, Shanghai, China.
Bioorganic & medicinal chemistry letters (impact factor: 2.65). 06/2010; 20(12):3521-5. DOI:10.1016/j.bmcl.2010.04.138 pp.3521-5
Source: PubMed

ABSTRACT A series of novel bicyclo[3.3.0]octane derivatives have been synthesized and found to be dipeptidyl peptidase 4 (DPP-4) inhibitors. Compounds 10a and 10b demonstrate good efficacies in oral glucose tolerance tests.

0 0
 · 
1 Bookmark
 · 
34 Views
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Keywords

dipeptidyl peptidase 4
 
DPP-4
 
good efficacies
 
novel bicyclo[3.3.0]octane derivatives
 

Tang Peng Cho